PETER NARA, D.V.M., PH.D, FAAAS.

Chief Business Officer 

President and Chairman of the Board of Biological Mimetics, has 18 years of successful co-founding and growing discovery biotechnology companies.  In addition to this Dr. Nara was elected aFellow to the American Association for the Advancement of Science in 2011 and has served on numerous commercial and private foundation boards of directors in advisory capacity for business development and/or science and technical   direction.  Dr. Nara has held leadership positions in academia, government (both non-military and military), and private sector ventures. Related to oncology he was a post-doctoral fellow at the National Cancer Institute where later he became Section Chief at the Frederick Cancer Research and Development Facility in Frederick, Maryland for 16 years.  Dr. Nara was the lead scientist in developing the Immune Refocusing Technology which will be used in the development of immuno-biologicals to be used in the Lantern oncology programs. As well his executive business development experience at Biological Mimetics Inc. along with his science and technology expertise will provide a sound advisory leadership role for the establishment of new company in Texas to translate lead discovery drugs and biological into realized products for patients suffering from this difficult disease.

SITE MAP
Home - Products Pipeline - Team  - Investors - News - Partnerships - Contact - Career
Copyright 2016 Lantern Pharma.  All rights reserved. 
designed & developed by Intuition Softwares.